Opsens Inc V.OPS

Primary Symbol: T.OPS

Healthcare Medical Devices

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

TSX:OPS - Post by User

Opsens Inc > first commercial use Savvywire (TM)

<< Previous

Bullboard Posts

Next >>

Post by Possibleidiot01on Jun 07, 2022 10:10am

154 Views

Post# 34736708

first commercial use Savvywire (TM)

Key word - significant !
Timeline reiterated.

. As the TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the benefits of the SavvyWire could be significant."

Following the marketing approval received from Health Canada ahead of schedule in April 2022 , OpSens has begun a controlled release to a limited number of hospitals in Canada . U.S. Food and Drug Administration clearance is expected this fall, with full commercial launch in early 2023.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December